United States Contraceptive Devices Market 2033 | Growth Drivers, Trends & Market Forecast, Competitive Landscape & Investment Opportunities

Market Size and Growth 2026

The Global Contraceptive Devices Market reached US$10.98 billion in 2024 and is expected to reach US$19.37 billion by 2033, growing at a CAGR of 6.6% during the forecast period of 2026-2033.

Download Free Sample Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/contraceptive-devices-market?sb

DataM Intelligence has released a new research report titled Contraceptive Devices Market Size 2026 The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the global Contraceptive Devices market.

Key Developments 2025-2026:

United States: Recent Industry Developments

✅ In March 2026, CooperCompanies expanded its contraceptive device portfolio through the launch of advanced long-acting reversible contraceptive solutions designed for improved patient comfort and efficacy. The development focuses on expanding women's reproductive healthcare access across clinical settings. It strengthens the company's presence in contraceptive technologies.

✅ In February 2026, Organon invested in expanding manufacturing capabilities for contraceptive implants and intrauterine devices in the U.S. The investment aims to improve product availability and support growing demand for long-term contraception solutions. It reinforces Organon's commitment to women's healthcare innovation.

✅ In January 2026, Bayer introduced updated digital support programs alongside its contraceptive device portfolio to improve patient education and adherence. The initiative integrates telehealth and reproductive health management tools for healthcare providers. It enhances accessibility and personalized contraceptive care in the U.S.

✅ In January 2026, Viatris announced a strategic collaboration with healthcare providers to expand distribution of affordable contraceptive devices across underserved communities. The program focuses on improving access to reproductive health solutions and patient awareness. It supports broader women's healthcare initiatives in the country.

Ready to scale in the Contraceptive Devices Market? Connect with the right partners and unlock new growth opportunities today:- https://www.datamintelligence.com/partner-identification-enquiry/contraceptive-devices-market?sb

Japan: Recent Industry Developments

✅ In March 2026, Fuji Pharma expanded its women's healthcare portfolio with new investments in contraceptive device distribution and reproductive health partnerships. The initiative focuses on increasing awareness and accessibility of modern contraceptive solutions. It strengthens the company's role in Japan's women's healthcare market.

✅ In February 2026, Terumo Corporation launched enhanced contraceptive healthcare support solutions integrated with digital patient management systems. The development aims to improve reproductive healthcare efficiency and patient engagement. It supports Japan's growing focus on advanced healthcare technologies.

✅ In January 2026, Daiichi Sankyo invested in reproductive healthcare R&D programs focused on next-generation contraceptive technologies and women's wellness solutions. The initiative supports innovation in safer and more effective contraceptive care. It strengthens Japan's reproductive healthcare ecosystem.

✅ In January 2026, Otsuka Holdings expanded collaborations with healthcare institutions to improve access to contraceptive devices and women's health services across Japan. The initiative emphasizes education, accessibility, and long-term reproductive care support. It aligns with the country's evolving healthcare priorities.

List of Key Players 2026:

=> CooperSurgical, Inc., Pregna International Limited, Reckitt Benckiser Group, Veru Inc., Bayer AG, Abbvie Inc., EUROGINE, S.L., Mona Lisa N.V., Prosan International BV, and OCON Medical Ltd., among others.

Growth Forecast Projection 2026:

The Global Contraceptive Devices Market is anticipated to rise at a considerable rate during the forecast period, between 2026 and 2033. In 2025, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Request Strategic Market Customization: https://datamintelligence.com/customize/contraceptive-devices-market?sb

How Our Market Research Process Works:

The global Contraceptive Devices Market research report is developed using a comprehensive combination of primary and secondary data sources. The study evaluates a wide range of industry-influencing factors, including government regulations, evolving market dynamics, competitive intensity, and historical performance trends. It also analyzes technological advancements, emerging innovations, and developments across related industries. In addition, the report assesses market volatility, growth opportunities, potential barriers, and key challenges that could impact the future expansion of the Contraceptive Devices ecosystem.

Recent Mergers & Acquisitions (M & A) 2025-2026:

✅ In April 2026, Sun Pharmaceutical Industries announced the acquisition of Organon in an approximately $11.75 billion deal, significantly strengthening its global women's health and contraceptive devices portfolio, including the well-known Nexplanon contraceptive implant.

✅ In April 2026, Johnson & Johnson signed an agreement to acquire AtraVerse Medical expanding its minimally invasive medical device capabilities and strengthening its broader reproductive and women's healthcare technology ecosystem.

✅ In March 2026, Embecta announced the acquisition of Owen Mumford for up to $199.4 million, enhancing its drug-delivery and medical-device portfolio, including technologies applicable to women's healthcare and contraceptive delivery systems.

✅ In February 2026, Organon entered into an exclusive licensing agreement with Sebela Pharmaceuticals for the hormone-free copper IUD MIUDELLA®, in a deal valued at over $532 million including milestone payments. The agreement strengthens Organon's long-term contraceptive device portfolio.

Unlock Full 360° Strategic Report: https://www.datamintelligence.com/buy-now-page?report=contraceptive-devices-market?sb

Major Focused Key Segmentations 2026:

➥ By Product Type: Condoms, Diaphragms & Cervical Caps, Sponges, Vaginal Rings, Intrauterine Devices (IUDs), Sub-Dermal Implants

➥ By Technology: Hormonal Contraceptives, Barrier Contraceptives

➥ By Gender: Male, Female

➥ By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Channels, Others

➥ By Region: North America, Latin America, Europe, Asia Pacific, Middle East & Africa - Share, Size, Outlook, and Opportunity Analysis

Regional Growth Analysis for Market:

⇥ North America: Leads the Contraceptive Devices market with strong R&D investments, advanced material innovation, and growing adoption across electronics, energy storage, and aerospace sectors.

⇥ Asia-Pacific (including Japan): Dominates global demand, driven by large-scale production, expanding applications in electronics, batteries, and industrial manufacturing across China, Japan, and India.

⇥ Europe: Significant growth supported by government-funded research initiatives, sustainability focus, and increasing use in automotive and renewable energy applications.

⇥ Middle East & Africa: Emerging market fueled by rising interest in advanced materials, infrastructure development, and early-stage adoption in energy and construction sectors.

We Provide Benefits of the Report:

Chapter 1: Lays the foundation by defining the scope of the report, highlighting core market segments across regions, product types, and applications. It delivers a clear snapshot of current market size, growth potential, and how the industry is expected to evolve in both the near and long term.

Chapter 2: Spotlights the most impactful market insights, unveiling the transformative trends and forces shaping the future of the industry.

Chapter 3: Provides a deep dive into the competitive landscape of , covering revenue shares, strategic initiatives, and notable mergers & acquisitions that are reshaping the market.

Chapter 4: Presents detailed company profiles of leading players featuring financial performance, product portfolios, profit margins, and key milestones that set them apart in the industry.

Chapters 5 & 6: Break down revenue analysis at both regional and country levels, offering precise data on market size, growth drivers, and expansion opportunities across global markets.

Chapter 7: Analyzes the market by product type, spotlighting segment-specific opportunities and helping stakeholders identify untapped, high-growth areas.

Chapter 8 :Explores the market through application-based segmentation, assessing demand across industries and pinpointing downstream sectors with the strongest potential for growth.

Chapter 9: Maps the industry's supply chain in detail, tracing upstream and downstream activities to provide clarity on value creation across the ecosystem.

Chapter 10: Wraps up with a concise summary of the report's key insights distilling the most critical findings and strategic takeaways for decision-makers and stakeholders.

FAQ

Q1: What is the current size of the Contraceptive Devices Market?

A: The Contraceptive Devices Market was valued at US$10.98 billion in 2024 and is forecasted to hit US$19.37 billion by 2033

Q2: How rapidly will the Market expanding?

A: The Contraceptive Devices market is projected to grow at a CAGR of 6.6% between 2026 and 2033.

Get Unlimited Market Reports & Strategic Insights: https://www.datamintelligence.com/reports-subscription

Contact:
Fabian
DataM Intelligence 4market Research LLP
6th Floor, M2 Tech Hub, DataM Intelligence 4market Research LLP, Lalitha Nagar, Habsiguda, Secunderabad, Hyderabad, Telangana 500039
USA: +1 877-441-4866
UK: +44 161-870-5507
Email: fabian@datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.